Skip to main navigation Skip to search Skip to main content

Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide

  • Wassim Abida
  • , Andrew W. Hahn
  • , Neal Shore
  • , Neeraj Agarwal
  • , Paul Sieber
  • , Matthew R. Smith
  • , Tanya Dorff
  • , Paul Monk
  • , Matthew Rettig
  • , Rupal Patel
  • , Anne Page
  • , Maureen Duff
  • , Rongda Xu
  • , Jian Wang
  • , Shravani Barkund
  • , Aleksandr Pankov
  • , Amber Wang
  • , Melissa R. Junttila
  • , Pratik S. Multani
  • , Anneleen Daemen
    • Edna Chow Maneval, Christopher J. Logothetis, Michael J. Morris

Research output: Contribution to journal › Article › peer-review

11   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science